Journal article
Regional comparison of self-reported late pregnancy cigarette smoking to mass spectrometry analysis
Journal of perinatology, Vol.41(10), pp.2417-2423
10/01/2021
DOI: 10.1038/s41372-021-01045-2
PMID: 33758398
Abstract
Objective To report a more accurate prevalence estimate of late pregnancy nicotine exposures. Study design A cross-sectional study during a 2-month period in 2019. Participants were women delivering in any of the six county maternity hospitals who consented to universal drug testing at the time of delivery as part of routine hospital admission. Results Of 2531 tested samples, 18.7% tested positive for high levels of cotinine indicating primary smoking or other primary use of tobacco products. Together, 33.0% of the study population tested positive for nicotine exposure during late pregnancy compared to vital records which reported 8.2% cigarette smoking during the third trimester of pregnancy and 10.5% cigarette smoking at any time during pregnancy through maternal self-report. Conclusion Captured vital birth smoking measures vastly underreport actual primary exposures to nicotine products. Vital birth data also fail to capture secondhand exposures which constitute a significant proportion of the population.
Details
- Title: Subtitle
- Regional comparison of self-reported late pregnancy cigarette smoking to mass spectrometry analysis
- Creators
- Eric S. Hall - Geisinger Medical CenterJennifer M. McAllister - University of Cincinnati Medical CenterElizabeth A. Kelly - University of Cincinnati Medical CenterKenneth D. R. Setchell - University of Cincinnati Medical CenterVandana Megaraj - Cincinnati Children's Hospital Medical CenterKristine L. Jimenez - Cincinnati Children's Hospital Medical CenterNichole Nidey - Cincinnati Children's Hospital Medical CenterJames M. Greenberg - University of Cincinnati Medical CenterScott L. Wexelblatt - University of Cincinnati Medical Center
- Resource Type
- Journal article
- Publication Details
- Journal of perinatology, Vol.41(10), pp.2417-2423
- DOI
- 10.1038/s41372-021-01045-2
- PMID
- 33758398
- NLM abbreviation
- J Perinatol
- ISSN
- 0743-8346
- eISSN
- 1476-5543
- Publisher
- Springer Nature
- Number of pages
- 7
- Grant note
- Amgis Foundation Inc. Chiesi Farmaceutici; Chiesi Pharmaceuticals Inc
- Language
- English
- Date published
- 10/01/2021
- Academic Unit
- Epidemiology; Addiction Medicine; Craniofacial Anomalies Research Center
- Record Identifier
- 9984446537402771
Metrics
7 Record Views